Page last updated: 2024-10-27

berotek and Bronchiectasis

berotek has been researched along with Bronchiectasis in 2 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Bronchiectasis: Persistent abnormal dilatation of the bronchi.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, MB1
Reen, DJ1
Fitzgerald, MX1
Hassan, JA1
Saadiah, S1
Roslan, H1
Zainudin, BM1

Trials

1 trial available for berotek and Bronchiectasis

ArticleYear
Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis.
    Respirology (Carlton, Vic.), 1999, Volume: 4, Issue:4

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Bronchiectasis; Bronchodilator Ag

1999

Other Studies

1 other study available for berotek and Bronchiectasis

ArticleYear
Atopy, immunological changes, and respiratory function in bronchiectasis.
    Thorax, 1984, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Bronchiectasis; Female; Fenoterol; Humans; Hypersensitivity, Immediate; Immunoglo

1984